Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950129-08-001934
Filing Date
2008-03-27
Accepted
2008-03-26 20:06:00
Documents
5
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 10-K h55008a1e10vkza.htm 10-K/A 456189
2 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) AND RULE 15D-14(A) h55008a1exv31w1.htm EX-31.1 7239
3 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) AND RULE 15D-14(A) h55008a1exv31w2.htm EX-31.2 7502
4 CERTIFICATION PURSUANT TO SECTION 906 h55008a1exv32w1.htm EX-32.1 3253
5 CERTIFICATION PURSUANT TO SECTION 906 h55008a1exv32w2.htm EX-32.2 2974
  Complete submission text file 0000950129-08-001934.txt   478706
Mailing Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081
Business Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081 7137968822
ENCYSIVE PHARMACEUTICALS INC (Filer) CIK: 0000887023 (see all company filings)

EIN.: 133532643 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-20117 | Film No.: 08713304
SIC: 2834 Pharmaceutical Preparations